Article Text

Download PDFPDF
Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient management

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors The authors are responsible for the full content.

  • Funding JP is supported by the SIRIC Cancer Research and Personalized Medicine (CARPEM), Multi-Organism Institute (ITMO) Aviesan Cancer (National Alliance for Life Sciences and Health), Institut National du Cancer (INCa), Agence Nationale de la Recherche sur le Sida et les Hépatites (ANRS) and Fondation pour la Recherche Médicale (FRM). LF is supported by PRIN (2022AHM4AA).

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles